Echocardiographic features of amyloid cardiomyopathy phenotypes in patients with different types of amyloidosis
- Authors: Сhaikovskaya O.Y.1, Saidova M.A.1, Dobrovolskaya S.V.1, Shoshina A.A.1, Nasonova S.N.1, Zhirov I.V.1, Tereshchenko S.N.1
-
Affiliations:
- Chazov National Medical Research Center of Cardiology
- Issue: Vol 97, No 4 (2025): Вопросы диагностики
- Pages: 315-321
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/292175
- DOI: https://doi.org/10.26442/00403660.2025.04.203168
- ID: 292175
Cite item
Full Text
Abstract
Aim. To determine the echocardiographic variants of phenotype presentation of amyloid cardiomyopathy (ACM) in patients with different types of amyloidosis.
Materials and methods. The study included 54 patients with ACM: 27 with light chain amyloidosis (15 [56%] males; the median age was 63.0 [56.5; 67.0]) and 27 patients with transthyretin amyloidosis (20 [74%] males; the median age was 73.0 [65.5; 78.5]). Standard echocardiographic parameters and the left ventricular (LV) global longitudinal strain in both groups were evaluated.
Results. Among patients with ACM, the following phenotypes were reported: hypertrophic phenotype (HP), a combination of hypertrophic and restrictive phenotypes (HP+RP), a combination of hypertrophic, restrictive phenotypes and ejection fraction (EF) less than 50% (HP+RP+EF<50%), and patients with minimal structural changes. In patients with HP+RP+EF<50%, significantly greater thickness of the LV posterior wall (p=0.025) and the relative wall thickness (p=0.010) were found; the LV global longitudinal strain was lower (p=0.001). There were significant differences in the size of the right atrium (p=0.036), the systolic pressure in the pulmonary artery (p<0.001), and the presence of a thickening of the free wall of the right ventricle (p<0.007) in the HP+RP group. Involvement of the heart valves was more common in patients with ATTR ACM.
Conclusion. After reviewing the echocardiographic data of patients, various phenotypic presentations of ACM and several correlations between echocardiographic characteristics depending on the type of amyloidosis were determined. Further study of echocardiographic parameters in patients with various types of amyloidosis may be promising for early diagnosis and proper treatment of ACM.
Full Text
##article.viewOnOriginalSite##About the authors
Olga Ya. Сhaikovskaya
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: O.Chaykovskaya@rambler.ru
ORCID iD: 0000-0002-2251-1675
врач функциональной диагностики отд-ния ультразвуковой диагностики
Russian Federation, MoscowMarina A. Saidova
Chazov National Medical Research Center of Cardiology
Email: O.Chaykovskaya@rambler.ru
ORCID iD: 0000-0002-3233-1862
доктор медицинских наук, профессор, рук. отд. ультразвуковых методов исследования
Russian Federation, MoscowSvetlana V. Dobrovolskaya
Chazov National Medical Research Center of Cardiology
Email: O.Chaykovskaya@rambler.ru
ORCID iD: 0000-0003-0580-393X
кандидат медицинских наук, младший научный сотрудник отд. ультразвуковых методов исследования
Russian Federation, MoscowAnastasia A. Shoshina
Chazov National Medical Research Center of Cardiology
Email: O.Chaykovskaya@rambler.ru
ORCID iD: 0000-0002-9519-7373
аспирант отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowSvetlana N. Nasonova
Chazov National Medical Research Center of Cardiology
Email: O.Chaykovskaya@rambler.ru
кандидат медицинских наук, старший научный сотрудник отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowIgor V. Zhirov
Chazov National Medical Research Center of Cardiology
Email: O.Chaykovskaya@rambler.ru
ORCID iD: 0000-0002-4066-2661
доктор медицинских наук, вед. науч. сотр. отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowSergey N. Tereshchenko
Chazov National Medical Research Center of Cardiology
Email: O.Chaykovskaya@rambler.ru
ORCID iD: 0000-0001-9234-6129
доктор медицинских наук, профессор, рук. отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowReferences
- Muchtar E, Dispenzieri A, Magen H, et al. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021;289(3):268-92. doi: 10.1111/joim.13169
- Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med. 2017;84(12 Suppl. 3):12-26. doi: 10.3949/ccjm.84.s3.02
- Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012;126(10):1286-300. doi: 10.1161/CIRCULATIONAHA.111.078915
- Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018;18(Suppl. 2):s30-5. doi: 10.7861/clinmedicine.18-2-s30
- Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/ HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2 – evidence base and standardized methods of imaging. J Nucl Cardiol. 2019;26(6):2065-123. doi: 10.1007/s12350-019-01760-6
- Yilmaz A, Bauersachs J, Bengel F, et al. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK). Clin Res Cardiol. 2021;110(4):479-506. doi: 10.1007/s00392-020-01799-3
- Kazi DS, Bellows BK, Baron SJ, et al. Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy. Circulation. 2020;141(15):1214-24. doi: 10.1161/CIRCULATIONAHA.119.045093
- Bistola V, Parissis J, Foukarakis E, et al. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis. Heart Fail Rev. 2021;26(4):861-79. doi: 10.1007/s10741-020-10062-w
- Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/ HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2 – Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2020;27(2):659-73. doi: 10.1007/s12350-019-01761-5
- Терещенко С.Н., Жиров И.В., Моисеева О.М., и др. Практические рекомендации по диагностике транстиретиновой амилоидной кардиомиопатии (ATTR-КМП или транстиретинового амилоидоза сердца). Терапевтический архив. 2022;94(4):584-95 [Tereshchenko SN, Zhirov IV, Moiseeva OM, et al. Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis). Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(4):584-95 (in Russian)]. DOI:0.26442/00403660.2022.04.201465
- Cuddy SAM, Chetrit M, Jankowski M, et al. Practical Points for Echocardiography in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022;35(9):A31-40. doi: 10.1016/j.echo.2022.06.006
- Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442-8. doi: 10.1136/heartjnl-2012-302353
- Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270-6. doi: 10.1093/eurheartj/ehm342
- Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-626. doi: 10.1093/eurheartj/ehad194
- Благова О.В., Недоступ А.В., Коган Е.А. Болезни миокарда и перикарда. От синдромов к диагнозу и лечению. М. 2019 [Blagova OV, Nedostup AV, Kogan EA. Bolezni miokarda i perikarda. Ot sindromov k diagnozu i lecheniiu. Moscow. 2019 (in Russian)].
- Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. doi: 10.1016/j.echo.2016.01.011
- Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1-64. doi: 10.1016/j.echo.2018.06.00418
- Rapezzi C, Aimo A, Barison A, et al. Restrictive cardiomyopathy: definition and diagnosis. Eur Heart J. 2022;43(45):4679-93. doi: 10.1093/eurheartj/ehac543
- Knight DS, Zumbo G, Barcella W, et al. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC Cardiovasc Imaging. 2019;12(5):823-33. doi: 10.1016/j.jcmg.2018.02.016
- Marcoux J, Mangione PP, Porcari R, et al. A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Mol Med. 2015;7(10):1337-49. doi: 10.15252/emmm.201505357
- Cantarutti C, Mimmi MC, Verona G, et al. Calcium Binds to Transthyretin with Low Affinity. Biomolecules. 2022;12(8):1066. doi: 10.3390/biom12081066
- Aimo A, Fabiani I, Maccarana A, et al. Valve disease in cardiac amyloidosis: an echocardiographic score. Int J Cardiovasc Imaging. 2023;39:1873-87. doi: 10.1007/s10554-023-02901-2
Supplementary files
